Trends in the age of hospitalized patients with urological cancers: A 17-year experience

Ishii N, Hatakeyama S, Miura H, Tanaka R, Oishi T, Horiguchi H, Hosogoe S, Fujita N, Iwamura H, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C.

International Journal of Urology   2023.3

Relationship between lower urinary tract symptoms and frailty

Ishii N, Hatakeyama S, Miura H, Tanaka R, Oishi T, Horiguchi H, Hosogoe S, Fujita N, Iwamura H, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C.

International Journal of Urology   2023.3

Trends of incidence and age in adults with testicular germ cell tumors: a two-decade multicenter retrospective study.

Ozaki Y, Narita T, Hatakeyama S, Tanaka T, Togashi K, Hamaya T, Ozaki K, Ishi N, Oishi T, Tokui N, Mikami J, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C.

Translational Andrology and Urology   2023.2

Effects of apalutamide dose reduction on skin-related adverse events in patients with advanced prostate cancer: A multicenter retrospective study

Oishi T, Hatakeyama S, Tabata R, Fujimori D, Kawashima Y, Tanaka R, Ishii N, Miura H, Tanaka T, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Sato S, Ohyama C

Prostate   2023.2

Can Erectile Dysfunction Severity Predict Major Adverse Cardiovascular Events in Men Undergoing Dialysis? A Prospective Cohort Study

Fujita N, Momota M, Ozaki Y, Tobisawa Y, Yoneyama T, Okamoto T, Yamamoto H, Hatakeyama S, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C.

World J Mens Health.   2023.1

Comparison of efficacy and medical costs between upfront docetaxel and abiraterone treatments of metastatic hormone-sensitive prostate cancer patients in real-world practice: a multicenter retrospective study

Ozaki K, Hatakeyama S, Narita S, Hata K, Yanagisawa T, Tanaka T, Togashi K, Hamaya T, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Kimura T, Habuchi T, Ohyama C.

World Journal of Urology   2023.1

Utility of the Age Discrepancy between Frailty-Based Biological Age and Expected Life Age in Patients with Urological Cancers

Togashi K, Hatakeyama S, Soma O, Okita K, Fujita N, Tanaka T, Noro D, Horiguchi H, Uemura N, Iwane T, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C.

Cancers   2022.12

Comparison of efficacy and medical costs between upfront docetaxel and abiraterone treatments of metastatic hormone-sensitive prostate cancer patients in real-world practice: a multicenter retrospective study

Ozaki K, Hatakeyama S, Narita S, Hata K, Yanagisawa T, Tanaka T, Togashi K, Hamaya T, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Kimura T, Habuchi T, Ohyama C.

World Journal of Urology   2022.12

Oncological and functional outcomes of female reproductive organ-sparing radical cystectomy and ileal neobladder construction

Miura H, Hatakeyama S, Tanaka T, Fujita N, Horiguchi H, Tanaka R, Noro D, Tokui N, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C.

Urologic Oncology: Seminars and Original Investigations   2022.12

Relationships of low-grade systemic inflammation and nutritional status with erectile dysfunction severity in men on dialysis.

2022.11

Humoral response after SARS-CoV-2 mRNA vaccination in patients with prostate cancer using steroids.

Ishii N, Hatakeyama S, Yoneyama T, Tanaka R, Narita T, Fujita N, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C.

Urologic Oncology: Seminars and Original Investigations   2022.10

Relationship between the cross-sectional area of the lumbar dural sac and lower urinary tract symptoms: A population-based cross-sectional study.

Oyama T, Wada K, Koyama K, Kumagai G, Tanaka S, Asari T, Imai A, Okamoto T, Hatakeyama S, Jung S, Sugimura Y, Ohyama C, Ishibashi Y.

PLOS ONE   2022.8

Association between Aortic Calcification Burden and the Severity of Erectile Dysfunction in Men Undergoing Dialysis: A Cross-Sectional Study.

Fujita N, Hatakeyama S, Momota M, Tobisawa Y, Yoneyama T, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C

World J Mens Health.   2022.3

Effects of six-cycle completion and earlier use of radium-223 therapy on prognosis for metastatic castration-resistant prostate cancer: A real-world multicenter retrospective study

Sasaki D, Hatakeyama S, Kawaguchi H, Hatayama Y, Ishibashi Y, Kusaka A, Noro D, Tanaka T, Ito H, Okuyama Y, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Aoki M, Ohyama C.

2022.2

Significance of pelvic lymph node dissection during radical prostatectomy in high-risk prostate cancer patients receiving neoadjuvant chemohormonal therapy

Iwamura H, Hatakeyama S, Narita T, Ozaki Y, Konishi S, Horiguchi H, Kodama H, Kojima Y, Fujita N, Okamoto T, Tobisawa Y, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C.

Scientific Reports   2022.1

Associations of impaired grip strength and gait function with the severity of erectile dysfunction in men undergoing dialysis: a cross-sectional study

Fujita N, Hatakeyama S, Momota M, Tobisawa Y, Yoneyama T, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C.

2021.12

Utility of total cell-free DNA levels for surgical damage evaluation in patients with urological surgeries

Scientific Reports   2021.11

Association between female urinary urgency and aponeurotic ptosis: Results from a community-based cross-sectional study in Japan.

Ozaki Y, Okamoto T, Miura Y, Iida K, Uemura N, Sugimura Y, Hatakeyama S, Urushidate S, Ohyama C

Neurourology and urodynamics   40 ( 6 )   1678 - 1685   2021.8

Impact of pretreatment anemia on upfront abiraterone acetate therapy for metastatic hormone-sensitive prostate cancer: a multicenter retrospective study.

Okamoto T, Noro D, Hatakeyama S, Narita S, Mitsuzuka K, Sakurai T, Kawamura S, Hoshi S, Shimoda J, Tanaka T, Kawaguchi T, Ishidoya S, Ito A, Tsuchiya N, Habuchi T, Ohyama C

BMC cancer   21 ( 1 )   605   2021.5

The effect of number of treatment cycles of platinum-based first-line chemotherapy on maximum radiological response in patients with advanced urothelial carcinoma.

Okita K, Hatakeyama S, Hagiwara K, Suzuki Y, Tanaka T, Noro D, Tokui N, Fujita N, Konishi S, Okamoto T, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C

Urologic oncology   2021.4

Prognostic significance of the Ki67 index and programmed death-ligand 1 expression after radical cystectomy in patients with muscle-invasive bladder cancer.

Horiguchi H, Hatakeyama S, Yoneyama T, Yoneyama MS, Tanaka T, Fujita N, Okamoto T, Yamamoto H, Yoneyama T, Yoshizawa T, Hashimoto Y, Kawaguchi T, Ohyama C

Urologic oncology   39 ( 4 )   238.e9 - 238.e17   2021.4

Prognostic significance of total plasma cell-free DNA level and androgen receptor amplification in castration-resistant prostate cancer.

Kubota Y, Hatakeyama S, Yoneyama T, Yoneyama MS, Hamano I, Konishi S, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C

World journal of urology   2021.3

The effect of frailty on the quality of life and lower urinary symptoms following robot-assisted radical prostatectomy: A longitudinal analysis (FRARP-QL Study).

Togashi K, Hatakeyama S, Kojima Y, Momota M, Narita T, Iwamura H, Hamano I, Hamaya T, Fujita N, Okamoto T, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C

Urologic oncology   39 ( 3 )   192.e7 - 192.e14   2021.3

Relationship of frailty with treatment modality selection in patients with muscle-invasive bladder cancer (FRART-BC study).

Iwamura H, Hatakeyama S, Momota M, Kojima Y, Narita T, Okamoto T, Fujita N, Hamano I, Togashi K, Hamaya T, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C

Translational andrology and urology   10 ( 3 )   1143 - 1151   2021.3

Effect of frailty and comorbidity on surgical contraindication in patients with localized prostate cancer (FRART-PC Study).

Kodama H, Hatakeyama S, Momota M, Togashi K, Hamaya T, Hamano I, Fujita N, Kojima Y, Okamoto T, Yoneyama T, Yamamoto H, Yoshikawa K, Yoneyama T, Hashimoto Y, Ohyama C

Urologic oncology   39 ( 3 )   191.e1 - 191.e8   2021.3

Trends in the use of neoadjuvant chemotherapy and oncological outcomes for high-risk upper tract urothelial carcinoma: a multicentre retrospective study.

Hamaya T, Hatakeyama S, Tanaka T, Kubota Y, Togashi K, Hosogoe S, Fujita N, Kusaka A, Tokui N, Okamoto T, Yamamoto H, Yoneyama T, Yoneyama T, Hashimoto Y, Ohyama C

BJU international   2021.1

Overactive bladder and sleep disturbance have a significant effect on indoor falls: Results from the community health survey in Japan.

Sakae Konishi, Shingo Hatakeyama, Atsushi Imai, Mika Kumagai, Kazutaka Okita, Kyo Togashi, Tomoko Hamaya, Itsuto Hamano, Teppei Okamoto, Hiromichi Iwamura, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

Lower urinary tract symptoms   13 ( 1 )   56 - 63   2021.1

Association between the baseline frailty and quality of life in patients with prostate cancer (FRAQ-PC study).

Tomoko Hamaya, Shingo Hatakeyama, Masaki Momota, Takuma Narita, Hiromichi Iwamura, Yuta Kojima, Itsuto Hamano, Naoki Fujita, Teppei Okamoto, Kyo Togashi, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

International journal of clinical oncology   26 ( 1 )   199 - 206   2021.1

The association between serum serotonin levels and overactive bladder: results from a community-based cross-sectional study in Japan.

Okamoto T, Hatakeyama S, Imai A, Yamamoto H, Yoneyama T, Mori K, Yoneyama T, Hashimoto Y, Nakaji S, Ohyama C

World journal of urology   39 ( 1 )   169 - 175   2021.1

Overactive bladder and sleep disturbance have a significant effect on indoor falls: Results from the community health survey in Japan.

Konishi S, Hatakeyama S, Imai A, Kumagai M, Okita K, Togashi K, Hamaya T, Hamano I, Okamoto T, Iwamura H, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C

Lower urinary tract symptoms   13 ( 1 )   56 - 63   2021.1

Association between the baseline frailty and quality of life in patients with prostate cancer (FRAQ-PC study).

Hamaya T, Hatakeyama S, Momota M, Narita T, Iwamura H, Kojima Y, Hamano I, Fujita N, Okamoto T, Togashi K, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C

International journal of clinical oncology   26 ( 1 )   199 - 206   2021.1

RARCと回腸を利用した尿路変向術

米山 高弘, 畠山 真吾, 橋本 安弘, 大山 力, 富樫 赳, 堀口 裕貴, 小玉 寛健, 成田 拓磨, 岩村 大径, 小島 由太, 岡本 哲平, 山本 勇人

Japanese Journal of Endourology   34 ( 1 )   24 - 32   2021

A Longitudinal Study of Bidirectional Relationships between Sleep Disorder and Frequency of Nocturia: Results from the Iwaki Health Promotion Project.

Konishi S, Hatakeyama S, Imai A, Kumagai M, Okamoto T, Okita K, Hamano I, Narita T, Kojima Y, Iwamura H, Yamamoto H, Yoneyama T, Yoneyama T, Hashimoto Y, Ohyama C

Urologia internationalis   105 ( 3-4 )   232 - 239   2021

Oncologic and patient-reported outcomes after robot-assisted radical prostatectomy in men aged ≥75 years.

Kyo Togashi, Shingo Hatakeyama, Teppei Okamoto, Yuta Kojima, Hiromichi Iwamura, Naoki Fujita, Takuma Narita, Itsuto Hamano, Tomoko Hamaya, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

Urologic oncology   2020.12

Oncologic and patient-reported outcomes after robot-assisted radical prostatectomy in men aged ≥75 years.

Togashi K, Hatakeyama S, Okamoto T, Kojima Y, Iwamura H, Fujita N, Narita T, Hamano I, Hamaya T, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C

Urologic oncology   2020.12

Prognostic significance of the Ki67 index and programmed death-ligand 1 expression after radical cystectomy in patients with muscle-invasive bladder cancer.

Hirotaka Horiguchi, Shingo Hatakeyama, Tohru Yoneyama, Mihoko Sutoh Yoneyama, Toshikazu Tanaka, Naoki Fujita, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Tadashi Yoshizawa, Yasuhiro Hashimoto, Toshiaki Kawaguchi, Chikara Ohyama

Urologic oncology   2020.12

A Longitudinal Study of Bidirectional Relationships between Sleep Disorder and Frequency of Nocturia: Results from the Iwaki Health Promotion Project.

Sakae Konishi, Shingo Hatakeyama, Atsushi Imai, Mika Kumagai, Teppei Okamoto, Kazutaka Okita, Itsuto Hamano, Takuma Narita, Yuta Kojima, Hiromichi Iwamura, Hayato Yamamoto, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

Urologia internationalis   1 - 8   2020.12

Pre-dialysis serum creatinine as an independent predictor of responsiveness to zinc supplementation among patients on hemodialysis.

Okamoto T, Hatakeyama S, Togashi K, Hamaya T, Tanaka Y, Imanishi K, Takashima T, Saitoh F, Suzuki T, Ohyama C

Clinical and experimental nephrology   24 ( 10 )   955 - 962   2020.10

Geriatric 8 screening of frailty in patients with prostate cancer.

Masaki Momota, Shingo Hatakeyama, Osamu Soma, Toshikazu Tanaka, Itsuto Hamano, Naoki Fujita, Teppei Okamoto, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Kazuaki Yoshikawa, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

International journal of urology : official journal of the Japanese Urological Association   27 ( 8 )   642 - 648   2020.8

Frailty is significantly associated with the type of urinary diversion in patients with muscle-invasive bladder cancer.

Kazutaka Okita, Shingo Hatakeyama, Masaki Momota, Osamu Soma, Itsuto Hamano, Toshikazu Tanaka, Hiromichi Iwamura, Naoki Fujita, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Chikara Ohyama

International journal of urology : official journal of the Japanese Urological Association   27 ( 8 )   649 - 654   2020.8

The effect of frailty on the quality of life and lower urinary symptoms following robot-assisted radical prostatectomy: A longitudinal analysis (FRARP-QL Study).

Kyo Togashi, Shingo Hatakeyama, Yuta Kojima, Masaki Momota, Takuma Narita, Hiromichi Iwamura, Itsuto Hamano, Tomoko Hamaya, Naoki Fujita, Teppei Okamoto, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

Urologic oncology   2020.8

The association between gut microbiome and erectile dysfunction: a community-based cross-sectional study in Japan.

Okamoto T, Hatakeyama S, Imai A, Yamamoto H, Yoneyama T, Mori K, Yoneyama T, Hashimoto Y, Nakaji S, Ohyama C

International urology and nephrology   52 ( 8 )   1421 - 1428   2020.8

Geriatric 8 screening of frailty in patients with prostate cancer.

Momota M, Hatakeyama S, Soma O, Tanaka T, Hamano I, Fujita N, Okamoto T, Yoneyama T, Yamamoto H, Imai A, Yoshikawa K, Yoneyama T, Hashimoto Y, Ohyama C

International journal of urology : official journal of the Japanese Urological Association   27 ( 8 )   642 - 648   2020.8

Frailty is significantly associated with the type of urinary diversion in patients with muscle-invasive bladder cancer.

Okita K, Hatakeyama S, Momota M, Soma O, Hamano I, Tanaka T, Iwamura H, Fujita N, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Yoshikawa K, Kawaguchi T, Ohyama C

International journal of urology : official journal of the Japanese Urological Association   27 ( 8 )   649 - 654   2020.8

Effect of frailty and comorbidity on surgical contraindication in patients with localized prostate cancer (FRART-PC Study).

Hirotake Kodama, Shingo Hatakeyama, Masaki Momota, Kyo Togashi, Tomoko Hamaya, Itsuto Hamano, Naoki Fujita, Yuta Kojima, Teppei Okamoto, Tohru Yoneyama, Hayato Yamamoto, Kazuaki Yoshikawa, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

Urologic oncology   2020.7

Utility of plasma cell-free DNA in metastatic castration-resistant prostate cancer.

Itsuto Hamano, Shingo Hatakeyama, Tomoko Hamaya, Kyo Togashi, Teppei Okamoto, Hayato Yamamoto, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

IJU case reports   3 ( 4 )   141 - 144   2020.7

Association of tumor burden with the eligibility of upfront intensification therapy in metastatic castration-sensitive prostate cancer: A multicenter retrospective study.

Shingo Hatakeyama, Shintaro Narita, Masahiro Takahashi, Toshihiko Sakurai, Sadafumi Kawamura, Senji Hoshi, Masanori Ishida, Toshiaki Kawaguchi, Shigeto Ishidoya, Jiro Shimoda, Hiromi Sato, Itsuto Hamano, Teppei Okamoto, Koji Mitsuzuka, Akihiro Ito, Norihiko Tsuchiya, Yoichi Arai, Tomonori Habuchi, Chikara Ohyama

International journal of urology : official journal of the Japanese Urological Association   27 ( 7 )   610 - 617   2020.7

Utility of plasma cell-free DNA in metastatic castration-resistant prostate cancer.

Hamano I, Hatakeyama S, Hamaya T, Togashi K, Okamoto T, Yamamoto H, Yoneyama T, Yoneyama T, Hashimoto Y, Ohyama C

IJU case reports   3 ( 4 )   141 - 144   2020.7

Association of tumor burden with the eligibility of upfront intensification therapy in metastatic castration-sensitive prostate cancer: A multicenter retrospective study.

Hatakeyama S, Narita S, Takahashi M, Sakurai T, Kawamura S, Hoshi S, Ishida M, Kawaguchi T, Ishidoya S, Shimoda J, Sato H, Hamano I, Okamoto T, Mitsuzuka K, Ito A, Tsuchiya N, Arai Y, Habuchi T, Ohyama C

International journal of urology : official journal of the Japanese Urological Association   27 ( 7 )   610 - 617   2020.7

Pre-dialysis serum creatinine as an independent predictor of responsiveness to zinc supplementation among patients on hemodialysis

Teppei Okamoto

Clinical and experimental nephrology   2020.6

The impact of microalbuminuria on overactive bladders: Results from a community‐based four‐year longitudinal study in Japan

Teppei Okamoto

Neurourology and Urodynamics   39 ( 5 )   1567 - 1575   2020.5

Altered gut microbiome associated with overactive bladder and daily urinary urgency

Teppei Okamoto

World Journal of Urology   39 ( 3 )   847 - 853   2020.5

Relationship between frailty and lower urinary tract symptoms among community-dwelling adults.

Osamu Soma, Shingo Hatakeyama, Atsushi Imai, Teppei Matsumoto, Itsuto Hamano, Naoki Fujita, Hiromichi Iwamura, Teppei Okamoto, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Shigeyuki Nakaji, Chikara Ohyama

Lower urinary tract symptoms   12 ( 2 )   128 - 136   2020.5

Relationship between frailty and lower urinary tract symptoms among community-dwelling adults.

Soma O, Hatakeyama S, Imai A, Matsumoto T, Hamano I, Fujita N, Iwamura H, Okamoto T, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Nakaji S, Ohyama C

Lower urinary tract symptoms   12 ( 2 )   128 - 136   2020.5

STone Episode Prediction: Development and validation of the prediction nomogram for urolithiasis.

Kazutaka Okita, Shingo Hatakeyama, Atsushi Imai, Toshikazu Tanaka, Itsuto Hamano, Teppei Okamoto, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Shigeyuki Nakaji, Tadashi Suzuki, Chikara Ohyama

International journal of urology : official journal of the Japanese Urological Association   27 ( 4 )   344 - 349   2020.4

STone Episode Prediction: Development and validation of the prediction nomogram for urolithiasis.

Okita K, Hatakeyama S, Imai A, Tanaka T, Hamano I, Okamoto T, Tobisawa Y, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Nakaji S, Suzuki T, Ohyama C

International journal of urology : official journal of the Japanese Urological Association   27 ( 4 )   344 - 349   2020.4

The association between serum serotonin levels and overactive bladder: results from a community-based cross-sectional study in Japan

畠山真吾、今井篤　他

World Journal of Urology   2020.3

The association between gut microbiome and erectile dysfunction: a community-based cross-sectional study in Japan

畠山真吾、今井篤、他

International Urology and Nephrology   2020.3

Influence of pretreatment quality of life on prognosis in patients with urothelial carcinoma.

Sappaya Suppanuntaroek, Shingo Hatakeyama, Naoki Fujita, Yuka Kubota, Yuichiro Suzuki, Teppei Okamoto, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Kazuyuki Mori, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

International journal of clinical oncology   25 ( 2 )   362 - 369   2020.2

Influence of pretreatment quality of life on prognosis in patients with urothelial carcinoma.

Suppanuntaroek S, Hatakeyama S, Fujita N, Kubota Y, Suzuki Y, Okamoto T, Tobisawa Y, Yoneyama T, Yamamoto H, Mori K, Imai A, Yoneyama T, Hashimoto Y, Ohyama C

International journal of clinical oncology   25 ( 2 )   362 - 369   2020.2

ハイリスク前立腺癌に対する術前内分泌化学療法後のロボット支援前立腺全摘術 (RARP) の治療成績

米山 高弘, 今井 篤, 畠山 真吾, 橋本 安弘, 大山 力, 濱谷 智子, 百田 匡毅, 濱野 逸人, 成田 拓磨, 岩村 大径, 小島 由太, 岡本 哲平, 山本 勇人

Japanese Journal of Endourology   33 ( 2 )   325 - 329   2020

Comparison of zinc acetate hydrate and polaprezinc for zinc deficiency in patients on maintenance hemodialysis: A single‐center, open‐label, prospective randomized study

畠山真吾、大山力　他

Therapeutic Apheresis and Dialysis   24 ( 5 )   568 - 577   2019.12

Validation and development of the CHAARTED criteria in patients with hormone‐naïve metastatic prostate cancer: A multi‐institutional retrospective study in Japan

畠山真吾、大山力　他

International Journal of Urology   27 ( 1 )   90 - 91   2019.10

Multicenter prospective study validating the efficacy of a quantitative assessment tool for frailty in patients with urological cancers.

Soma O, Hatakeyama S, Okamoto T, Fujita N, Hamano I, Tanaka T, Momota M, Yoneyama T, Yamamoto H, Imai A, Yoneyama T, Hashimoto Y, Yoshikawa K, Kawaguchi T, Saitoh H, Nakaji S, Suzuki T, Ohyama C

Medical oncology (Northwood, London, England)   36 ( 10 )   88   2019.9

The Relationship Between Gait Function and Erectile Dysfunction: Results from a Community-Based Cross-Sectional Study in Japan

畠山真吾、今井篤　他

The Journal of Sexual Medicine   16 ( 12 )   1922 - 1929   2019.9

Impact of nutritional status on the prognosis of patients with metastatic hormone-naïve prostate cancer: a multicenter retrospective cohort study in Japan.

Okamoto T, Hatakeyama S, Narita S, Takahashi M, Sakurai T, Kawamura S, Hoshi S, Ishida M, Kawaguchi T, Ishidoya S, Shimoda J, Sato H, Mitsuzuka K, Tochigi T, Tsuchiya N, Arai Y, Habuchi T, Ohyama C

World journal of urology   37 ( 9 )   1827 - 1835   2019.9

Robot-assisted radical cystectomy in a patient with muscle-invasive bladder cancer following radiotherapy for prostate cancer.

Kubota Y, Hatakeyama S, Hashimoto T, Fujita N, Okamoto T, Suzuki Y, Yamamoto H, Imai A, Yoneyama T, Hashimoto Y, Koie T, Ohyama C

IJU case reports   2 ( 4 )   236 - 239   2019.7

Impact of nutritional status on the prognosis of patients with metastatic hormone-naïve prostate cancer: a multicenter retrospective cohort study in Japan

Teppei Okamoto

World Journal of Urology   2018.12

Butyrylcholinesterase level as an independent factor of erythropoiesis-stimulating agent resistance in patients on maintenance hemodialysis: a single-center cross-sectional study.

Okamoto T, Hatakeyama S, Tanaka Y, Imanishi K, Takashima T, Saitoh F, Koie T, Suzuki T, Ohyama C

Clinical and experimental nephrology   22 ( 5 )   1174 - 1181   2018.10

Low serum butyrylcholinesterase is independently related to low fetuin-A in patients on hemodialysis: a cross-sectional study

Teppei Okamoto

International Urology and Nephrology   50 ( 9 )   1713 - 1720   2018.9

Proton pump inhibitor as an independent factor of progression of abdominal aortic calcification in patients on maintenance hemodialysis

Teppei Okamoto

PLOS ONE   13 ( 7 )   e0199160   2018.7

Clinical implication of a quantitative frailty assessment tool for prognosis in patients with urological cancers.

Soma O, Hatakeyama S, Okamoto T, Fujita N, Matsumoto T, Tobisawa Y, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Koie T, Nakaji S, Ohyama C

Oncotarget   9 ( 25 )   17396 - 17405   2018.4

Butyrylcholinesterase level as an independent factor of erythropoiesis-stimulating agent resistance in patients on maintenance hemodialysis: a single-center cross-sectional study.

Teppei Okamoto

Clinical and experimental nephrology   2018.3

The relationship between poor nutritional status and progression of aortic calcification in patients on maintenance hemodialysis.

Teppei Okamoto

BMC nephrology   2018.3

The relationship between poor nutritional status and progression of aortic calcification in patients on maintenance hemodialysis.

Okamoto T, Hatakeyama S, Kodama H, Horiguchi H, Kubota Y, Kido K, Momota M, Hosogoe S, Tanaka Y, Takashima T, Saitoh F, Suzuki T, Ohyama C

BMC nephrology   19 ( 1 )   71   2018.3

The influence of serum uric acid on renal function in patients with calcium or uric acid stone: A population-based analysis.

Tanaka Y, Hatakeyama S, Tanaka T, Yamamoto H, Narita T, Hamano I, Matsumoto T, Soma O, Okamoto T, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Takahashi I, Nakaji S, Terayama Y, Funyu T, Ohyama C

PloS one   12 ( 7 )   e0182136   2017

Slow Gait Speed and Rapid Renal Function Decline Are Risk Factors for Postoperative Delirium after Urological Surgery.

Sato T, Hatakeyama S, Okamoto T, Yamamoto H, Hosogoe S, Tobisawa Y, Yoneyama T, Hashiba E, Yoneyama T, Hashimoto Y, Koie T, Hirota K, Ohyama C

PloS one   11 ( 5 )   e0153961   2016

Surgery without Blood Transfusion for Giant Paraganglioma in a Jehovah's Witness Patient.

Narita T, Hamano I, Kusaka A, Murasawa H, Tokui N, Imanishi K, Okamoto T, Yamamoto H, Imai A, Hatakeyama S, Yoneyama T, Hashimoto Y, Koie T, Ohyama C, Hakamada K

Case reports in oncology   7 ( 1 )   233 - 8   2014.1

Blood group antigen-targeting peptide suppresses anti-blood group antibody binding to antigen in renal glomerular capillaries after ABO-incompatible blood reperfusion.

Yoneyama T, Hatakeyama S, Tobisawa Y, Yamamoto H, Imanishi K, Okamoto T, Tokui N, Sugiyama N, Suzuki Y, Kudo S, Yoneyama T, Hashimoto Y, Koie T, Kamimura N, Fukuda MN, Ohyama C

Transplantation   95 ( 3 )   418 - 25   2013.2

Carboplatin-gemcitabine combination chemotherapy upregulates AKR1B10 expression in bladder cancer

HASHIMOTO Yasuhiro, IMANISHI Kengo, TOKUI Noriko, OKAMOTO Teppei, OKAMOTO Akiko, HATAKEYAMA Shingo, YONEYAMA Takahiro, KOIE Takuya, KAMIMURA Noritaka, OHYAMA Chikara

International journal of clinical oncology   18 ( 1 )   177 - 182   2013.2

Carboplatin-gemcitabine combination chemotherapy upregulates AKR1B10 expression in bladder cancer.

Hashimoto Y, Imanishi K, Tokui N, Okamoto T, Okamoto A, Hatakeyama S, Yoneyama T, Koie T, Kamimura N, Ohyama C

International journal of clinical oncology   18 ( 1 )   177 - 82   2013.2

Core2 O-glycan-expressing prostate cancer cells are resistant to NK cell immunity.

Okamoto T, Yoneyama MS, Hatakeyama S, Mori K, Yamamoto H, Koie T, Saitoh H, Yamaya K, Funyu T, Fukuda M, Ohyama C, Tsuboi S

Molecular medicine reports   7 ( 2 )   359 - 64   2013.2

[Adult mature teratoma of the testis: a case report].

Imanishi K, Hatakeyama S, Okamoto T, Suzuki Y, Sugiyama N, Yamamoto H, Kudo S, Yoneyama T, Hashimoto Y, Koie T, Kamimura N, Ohyama C

Hinyokika kiyo. Acta urologica Japonica   59 ( 1 )   57 - 60   2013.1

Blood Group Antigen Targeting Peptide Suppresses Thrombotic Microangiopathy in Renal Glomerular Capillaries after ABO-Incompatible Blood Reperfusion

Yoneyama Tohru, Hatakeyama Shingo, Ymamoto Hayato, Imanishi Kengo, Okamoto Teppei, Tokui Noriko, Sugiyama Naoki, Suzuki Yuichiro, Kudo Shigemasa, Yoneyama Takahiro, Hashimoto Yasuhiro, Koie Takuya, Kamimura Noritaka, Fukuda Michiko N., Ohyama Chikara

弘前医学   64 ( 0 )   S121 - 128   2013

[Metastatic renal tumor from oral floor cancer: a case report].

Ishibashi Y, Hatakeyama S, Okamoto T, Suzuki Y, Kudo S, Yoneyama T, Koie T, Kamimura N, Sakaki H, Kobayashi W, Kimura H, Ohyama C

Hinyokika kiyo. Acta urologica Japonica   58 ( 11 )   609 - 12   2012.11

[Adrenal pheochromocytoma with multiple neurofibromatosis on the trunk].

Tokui N, Okamoto T, Imanishi K, Sugiyama N, Suzuki Y, Ishimura H, Hatakeyama S, Kudoh S, Yoneyama T, Koie T, Kamimura N, Ohyama C

Hinyokika kiyo. Acta urologica Japonica   58 ( 1 )   17 - 9   2012.1

Skin perfusion pressure is a prognostic factor in hemodialysis patients.

Hatakeyama S, Saito M, Ishigaki K, Yamamoto H, Okamoto A, Ishibashi Y, Murasawa H, Imanishi K, Tokui N, Okamoto T, Suzuki Y, Sugiyama N, Imai A, Kudo S, Yoneyama T, Hashimoto Y, Koie T, Kaminura N, Saitoh H, Funyu T, Ohyama C

International journal of nephrology   2012   385274   2012

Effect of an Oral Adsorbent, AST-120, on Dialysis Initiation and Survival in Patients with Chronic Kidney Disease.

Hatakeyama S, Yamamoto H, Okamoto A, Imanishi K, Tokui N, Okamoto T, Suzuki Y, Sugiyama N, Imai A, Kudo S, Yoneyama T, Hashimoto Y, Koie T, Kaminura N, Saitoh H, Funyu T, Ohyama C

International journal of nephrology   2012   376128   2012

Advancements in Urology 2011 : A Japanese Urological Association (JUA)/American Urological Association (AUA) Symposium

NAITO Seiji, EGAWA Shin, NAKAGAWA Masayuki, KAKEHI Yoshiyuki, FLANIGAN Robert C, HAYASHI Tetsutaro, OHARA Shinya, TEISHIMA Jun, SHOJI Koichi, SENTANI Kazuhiro, OUE Naohide, YASUI Wataru, MATSUBARA Akio, SAKAMOTO Shinichi, KAWAMURA Koji, IMAMOTO Takashi, NIHEI Naoki, KYPRIANOU Natasha, ICHIKAWA Tomohiko, HASHIMOTO Kohei, MASUMORI Naoya, TANAKA Toshiaki, KITAMURA Hiroshi, TSUKAMOTO Taiji, KIMURA Kyosuke, TSUKII Toyonori, KAMIHIRA Osanu, SASSA Naoto, KOMATSU Tomonori, HATTORI Ryohei, GOTOH Momokazu, SHIMIZU Shinjiro, JO Yoshimasa, YOKOYAMA Teruhiko, KAIFU Mikako, HARA Ryoei, FUJII Tomohiro, MIYAJI Yoshiyuki, NAGAI Atsushi, TSUZUKI Shunsuke, KIDO Masahito, YAMAMOTO Toshihiro, MIKI Jun, KIMURA Takahiro, MIKI Kenta, AOKI Manabu, EGAWA Shin, NAKANISHI Juro, WADA Yoshihiro, TAKAHASHI Wataru, HONDA Jiro, ETO Masatoshi, KITAGAWA Yasuhide, SHIGEHARA Kazuyoshi, MIWA Sotaro, MIYAGI Toru, KADONO Yoshifumi, KONAKA Hiroyuki, MIZOKAMI Atsushi, NAMIKI Mikio, KATO Takuma, YANO Toshifumi, HIRAMA Hiromi, UETSUKI Hiotsugu, TSUNEMORI Hiroyuki, INUI Masashi, SUGIMOTO Mikio, KAKEHI Yoshiyuki, ICHIMATSU Keisuke, IIDA Hiroaki, MORII Akihiro, YASUDA Kenji, WATANABE Akihiko, NOZAKI Tetsuo, KOMIYA Akira, FUSE Hideki, MAKI Yoshio, KURUMA Hidetoshi, GUST Kilian, MATSUMOTO Hiroaki, ZOUBEIDI Amina, FAZLI Ladan, LODDICK Sarah, BROOKS Nigel, GLEAVE Martin, CHOI Han Y, PARK Jong W, PARK Seo Y, LEE Hyun M, JEON Seong S, SEO Seong I, PARK Byung K, HIRAI Kenichi, NOMURA Takeo, YAMASAKI Mutsushi, MATSUBARA Takanori, SATO Fuminori, MIMATA Hiromitsu, SENO Yasuyuki, KATO Masao, MITA Koji, NOMURA Takeo, HUANG Wen-Chin, CHUNG Leland WK, MIMATA Hiromitsu, MURAKAMI Masaya, MIKI Jun, KIMURA Takahiro, HATANO Takashi, EGAWA Shin, MATSUTA Yosuke, AKINO Hironobu, NAMIKI Mikio, FUSE Hideki, SUZUKI Kouji, YOKOYAMA Osamu, ONIZUKA Chie, KAMIMURA Toshio, NAGANO Masafumi, YAMAGUCHI Takanori, KAMOTO Toshiyuki, HASHIMOTO Jiro, TAKAHASHI Satoshi, UEHARA Teruhisa, KURIMURA Yuichiro, TSUKAMOTO Taiji, FUKUMOTO Kazuhiko, YOKOYAMA Teruhiko, KAIFU Mikako, HARA Ryoei, FUJII Tomohiro, JO Yoshimasa, MIYAJI Yoshiyuki, NAGAI Atsushi, TORIMOTO Kazumasa, TAKAMI Takeshi, HIRAYAMA Akihide, KUWADA Masaomi, KAGEBAYASHI Yoriaki, SAMMA Shoji, FUJIMOTO Kiyohide, HIRAO Yoshihiko, ISHIURA Yoshiyuki, YAEGASHI Hiroshi, KOSHIDA Kiyoshi, MAEDA Yoshiko, SEKIGUCHI Yuki, SHITAMURA Takahiro, INOUE Katumi, NOSE Kiyotaka, KAMOTO Toshiyuki, HAYAMI Hiroshi, ENOKIDA Hideki, NAKAGAWA Masayuki, NAITO Seiji, MATSUMOTO Tetsuro, UOZUMI Jiro, MIMATA Hiromitsu, TAKEI Mineo, YOKOYAMA Teruhiko, FUKUMOTO Kazuhiko, HARA Ryoei, FUJII Tomohiro, JO Yoshimasa, MIYAJI Yoshiyuki, NAGAI Atsushi, KAMIMURA Noritaka, FUJITA Naoki, TOKUI Noriko, OKAMOTO Teppei, IMANISHI Kengo, SUGIYAMA Naoki, IMAI Atsushi, OHYAMA Chikara, YOSHINO Hirofumi, CHIYOMARU Takeshi, ENOKIDA Hideki, KAWAKAMI Kazumori, TATARANO Shuichi, NISHIYAMA Kenryu, SEKI Naohiko, NAKAGAWA Masayuki, TATARANO Shuichi, CHIYOMARU Takeshi, KAWAKAMI Kazumori, ENOKIDA Hideki, YOSHINO Hirofumi, NISHIYAMA Kenryu, SEKI Naohiko, NAKAGAWA Masayuki, SEGAWA Takehiko, TAKAHASHI Takeshi, MATSUMOTO Keiyu, SUMIYOSHI Takayuki, UTSUNOMIYA Noriaki, MUGURUMA Koei, KAWAKITA Mutsushi, IKEDA Hiroshi, NOMURA Masayoshi, SHOU Takehiko, ISHIKAWA Kaori, KASHIWAGI Eiji, DEJIMA Takashi, SANEFUJI Hayato, OKUMURA Kouji, YANAGISAWA Takafumi, MIKI Jun, ISHII Gen, BANDO Shigehiro, MIKI Kenta, EGAWA Shin, TANAKA Nobuyuki, KIKUCHI Eiji, MATSUMOTO Kazuhiro, MIYAJIMA Akira, NAKAGAWA Ken, OYA Mototsugu, ISHII Gen, MIKI Jun, TABATA Ryuji, KIMURA Takahiro, EGAWA Shin, KAWAMURA Koji, SAKAMOTO Shinichi, UTSUMI Takanobu, IMAMOTO Takashi, NIHEI Naoki, ICHIKAWA Tomohiko

International journal of urology   18 ( 5 )   388 - 408   2011.5

OP-156 限局性前立腺癌のブラキ治療後排尿障害に対するα1ブロッカーの効果について(前立腺腫瘍/放射線治療1,一般演題口演,第99回日本泌尿器科学会総会)

神村 典孝, 米山 徹, 盛 和行, 大山 力, 岡本 哲平, 得居 範子, 杉山 尚樹, 鈴木 裕一朗, 畠山 真吾, 工藤 茂将, 米山 高弘, 古家 琢也

日本泌尿器科学会雑誌   102 ( 2 )   2011

OP-186 CRPCに対するDocetaxel,Prednisolone,Zoledronic acid療法の検討(前立腺腫瘍/薬物療法2,一般演題口演,第99回日本泌尿器科学会総会)

米山 高弘, 古家 琢也, 神村 典孝, 羽渕 友則, 大山 力, 岡本 哲平, 得居 範子, 鈴木 裕一朗, 杉山 尚樹, 米山 徹, 畠山 真吾, 工藤 茂将, 盛 和行

日本泌尿器科学会雑誌   102 ( 2 )   2011

PP-318 前立腺全摘除術後の下部尿路機能評価 : 1年後の尿失禁の予測因子は何か(一般演題ポスター発表・討論,一般演題ポスター,第99回日本泌尿器科学会総会)

杉山 尚樹, 神村 典孝, 大山 力, 今西 賢吾, 岡本 哲平, 得居 範子, 鈴木 裕一朗, 畠山 真吾, 工藤 茂将, 米山 高弘, 古家 琢也

日本泌尿器科学会雑誌   102 ( 2 )   2011

PP-390 ABO血液型抗原をマスクするペプチド配列のスクリーニング(一般演題ポスター発表・討論,一般演題ポスター,第99回日本泌尿器科学会総会)

米山 徹, 盛 和行, 古家 琢也, 神村 典孝, 大山 力, 畠山 真吾, 今西 賢吾, 得居 範子, 岡本 哲平, 杉山 尚樹, 鈴木 裕一朗, 工藤 茂将, 米山 高弘

日本泌尿器科学会雑誌   102 ( 2 )   2011

Efficacy of SMART Stent Placement for Salvage Angioplasty in Hemodialysis Patients with Recurrent Vascular Access Stenosis.

Hatakeyama S, Toikawa T, Okamoto A, Yamamoto H, Imanishi K, Okamoto T, Tokui N, Suzuki Y, Sugiyama N, Imai A, Hashimoto Y, Kudo S, Yoneyama T, Koie T, Kamimura N, Saitoh H, Funyu T, Ohyama C

International journal of nephrology   2011   464735   2011

APP-039 日本人における限局性前立腺癌リスク分類の妥当性に関する検討(総会賞応募ポスター,第99回日本泌尿器科学会総会)

古家 琢也, 鈴木 裕一朗, 橋本 安弘, 大山 力, 得居 範子, 今西 賢吾, 岡本 哲平, 杉山 尚樹, 畠山 真吾, 工藤 茂将, 米山 高弘, 神村 典孝

日本泌尿器科学会雑誌   102 ( 2 )   2011

[Ganglioneuroma with calcification mimicking adrenal tumor: a case report].

Okamoto T, Suzuki Y, Sugiyama N, Kudo S, Yoneyama T, Hashimoto Y, Koie T, Kamimura N, Oyama C

Hinyokika kiyo. Acta urologica Japonica   56 ( 11 )   621 - 3   2010.11

OP-199 下部尿路症状と関連する液性因子の検討(Neurourology/臨床3,一般演題口演,第98回日本泌尿器科学会総会)

今井 篤, 古家 琢也, 吉川 和暁, 百瀬 昭志, 大山 力, 神村 典孝, 岡本 哲平, 鈴木 裕一朗, 杉山 尚樹, 立和田 得志, 工藤 茂将, 米山 高弘, 橋本 安弘

日本泌尿器科学会雑誌   101 ( 2 )   2010

OP-476 腹腔鏡手術を行った原発性アルドステロン症における術後血圧の変化について(副腎・後腹膜,一般演題口演,第98回日本泌尿器科学会総会)

神村 典孝, 大山 力, 二川原 健, 崎原 哲, 須田 俊宏, 岡本 哲平, 杉山 尚樹, 鈴木 裕一朗, 立和田 得志, 工藤 茂将, 米山 高弘, 橋本 安弘, 古家 琢也

日本泌尿器科学会雑誌   101 ( 2 )   2010

PP-065 筋層浸潤膀胱癌に対するゲムシタビン+カルボプラチンによる術前化学療法の有用性(発表・討論,一般演題ポスター,第98回日本泌尿器科学総会)

鈴木 裕一朗, 神村 典孝, 大山 力, 岡本 哲平, 今西 賢吾, 杉山 尚樹, 工藤 茂将, 盛 和行, 米山 高弘, 橋本 安弘, 古家 琢也

日本泌尿器科学会雑誌   101 ( 2 )   2010

PP-067 Cisplatin-unfit進行性膀胱癌に対する3段階化学療法の経験(発表・討論,一般演題ポスター,第98回日本泌尿器科学総会)

立和田 得志, 古家 琢也, 神村 典孝, 大山 力, 岡本 哲平, 今西 賢悟, 鈴木 裕一朗, 杉山 尚樹, 工藤 茂, 盛 和行, 米山 高弘, 橋本 安弘

日本泌尿器科学会雑誌   101 ( 2 )   2010

PP-175 High risk前立腺癌に対するLHRHアゴニスト+エストラムスチンのネオアジュバント療法に関するPhase II study(発表・討論,一般演題ポスター,第98回日本泌尿器科学会総会)

工藤 茂将, 神村 典孝, 大山 力, 岡本 哲平, 今西 賢吾, 鈴木 裕一朗, 杉山 尚樹, 盛 和行, 米山 高弘, 橋本 安弘, 古家 琢也

日本泌尿器科学会雑誌   101 ( 2 )   2010

PP-214 進行性上部尿路上皮癌に対するGemcitabine+Carboplatin療法の検討(発表・討論,一般演題ポスター,第98回日本泌尿器科学会総会)

米山 高弘, 古家 琢也, 神村 典孝, 大山 力, 今西 賢悟, 岡本 哲平, 杉山 尚樹, 鈴木 裕一朗, 工藤 茂将, 盛 和行, 立和田 得志, 橋本 安弘

日本泌尿器科学会雑誌   101 ( 2 )   2010

APP-092 回腸新膀胱における排尿機能の経時的変化 : 中長期成績における検討(発表・討論,総会賞応募ポスター,第98回日本泌尿器科学総会)

古家 琢也, 神村 典孝, 大山 力, 岡本 哲平, 今西 賢悟, 鈴木 裕一朗, 杉山 尚樹, 工藤 茂将, 盛 和行, 米山 高弘, 橋本 安弘

日本泌尿器科学会雑誌   101 ( 2 )   2010